ACG Secures Major Policy Wins on CRC Surveillance, Telehealth & PBM Reform
The American College of Gastroenterology (ACG) announced key advocacy victories in the newly signed $1.2 trillion federal funding package — with meaningful implications for colorectal cancer screening, telehealth access, and drug pricing reform.
🔎 Surveillance Colonoscopy Recognized in Federal Report Language
For the first time, Congressional appropriations language explicitly acknowledges the full colorectal cancer (CRC) screening continuum — including surveillance colonoscopy for patients with a history of polyps.
The report urges CMS to reference U.S. Multi-Society Task Force recommendations and highlights rising early-onset CRC rates.
While not statutory change, report language signals clear Congressional intent — strengthening ACG’s push to classify surveillance colonoscopy as a preventive service without cost-sharing.
📡 Medicare Telehealth Extended Through 2027
COVID-era Medicare telehealth flexibilities are extended through December 31, 2027, providing much-needed stability for GI practices and patients.
ACG continues to advocate for permanent reform through legislation like the CONNECT for Health Act.
💊 PBM Reform Act of 2025
The package includes new guardrails for pharmacy benefit managers (PBMs):
- Delinks PBM compensation from Medicare Part D drug list prices
- Introduces flat administrative fees
- Expands reporting and transparency requirements
The reforms apply to Medicare but stop short of broader commercial markets.
🧬 Additional Provisions Relevant to GI
- Multi-Cancer Early Detection (MCED) tests gain Medicare coverage beginning in 2029 for FDA-approved tests
- Dr. Lorna Breen Act reauthorized through 2030, with emphasis on reducing administrative burden and supporting clinician mental health